BCI Pharma is delighted to announce that the company has been acquired by Gedeon Richter.

Dominique Surleraux, former BCI Pharma CEO, said : “This acquisition will ensure the continuity and development of the BCI and also further clinical development of our assets/research projects. I would like to take the opportunity to thank BCI scientists for their input, BCI investors and the Belgium Walloon region Ministry of economic (SPW wallonie) for their financial support. I’m pretty confident that our assets will improve the quality of life of patients suffering from cancer and endometriosis.”

Follow the link to read Gedeon Richter’s press release